Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,24 € ↓ -0,74 (-1,16%)
2026-06-05
DEL PRIS
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionMarshall Wace, Llp
Latest Disclosed Ownership18,692 shares
Latest Disclosed Value $ 753,475
Marshall Wace, Llp ownership in HTD / Corcept Therapeutics Incorporated

On May 14, 2026 - Marshall Wace, Llp filed a 13F-HR form disclosing ownership of 18,692 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $644,687 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 13, 2025 disclosing 0 shares of Corcept Therapeutics Incorporated. The current value of the position is $1,182,082 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F CORCEPT THERA COMMON STOCK 218352102 18,692 18,692 753 0.0004
2025-11-13 2025-09-30 13F CORCEPT THERA COMMON STOCK 218352102 0 -46,200 -100.00 0 -100.00
2025-08-13 2025-06-30 13F CORCEPT THERA COMMON STOCK 218352102 46,200 41,040 795.35 3,391 475.72 0.0038
2025-05-15 2025-03-31 13F CORCEPT THERA COMMON STOCK 218352102 5,160 5,160 589 0.0007
2024-11-14 2024-09-30 13F CORCEPT THERA COMMON STOCK 218352102 0 -20,200 -100.00 0 -100.00
2024-08-14 2024-06-30 13F CORCEPT THERA COMMON STOCK 218352102 20,200 -78,299 -79.49 656 -73.56 0.0009
2024-05-15 2024-03-31 13F CORCEPT THERA COMMON STOCK 218352102 98,499 98,499 2,481 0.0038
2024-02-14 2023-12-31 13F CORCEPT THERA COMMON STOCK 218352102 0 -19,042 -100.00 0 -100.00
2023-11-14 2023-09-30 13F CORCEPT THERA COMMON STOCK 218352102 19,042 -168,584 -89.85 519 -87.59 0.0011
2023-08-14 2023-06-30 13F CORCEPT THERA COMMON STOCK 218352102 187,626 65,500 53.63 4,175 57.81 0.0082
2023-05-15 2023-03-31 13F CORCEPT THERA COMMON STOCK 218352102 122,126 122,126 2,645 0.0056
2023-02-14 2022-12-31 13F CORCEPT THERA COMMON STOCK 218352102 0 -29,372 -100.00 0 -100.00
2022-11-14 2022-09-30 13F CORCEPT THERA COMMON STOCK 218352102 29,372 -25,596 -46.57 753 -42.39 0.0016
2022-08-15 2022-06-30 13F CORCEPT THERA COMMON STOCK 218352102 54,968 54,968 1,307 0.0027
2021-11-15 2021-09-30 13F CORCEPT THERA COMMON STOCK 218352102 0 -9,941 -100.00 0 -100.00
2021-08-13 2021-06-30 13F CORCEPT THERA COMMON STOCK 218352102 9,941 -36,337 -78.52 219 -80.11 0.0011
2021-05-17 2021-03-31 13F CORCEPT THERA COMMON STOCK 218352102 46,278 -205,122 -81.59 1,101 -83.26 0.0050
2021-02-16 2020-12-31 13F CORCEPT THERA COMMON STOCK 218352102 251,400 -298,682 -54.30 6,577 -31.33 0.0356
2020-11-16 2020-09-30 13F CORCEPT THERA COMMON STOCK 218352102 550,082 550,082 118.81 9,578 45.63 0.0613
2020-08-13 2020-06-30 13F CORCEPT THERA COMMON STOCK 218352102 0 -538,555 -100.00 0 -100.00
2020-05-15 2020-03-31 13F CORCEPT THERA COMMON STOCK 218352102 538,555 484,178 890.41 6,403 873.10 0.0640
2020-02-14 2019-12-31 13F CORCEPT THERA COMMON STOCK 218352102 54,377 -235,809 -81.26 658 -83.95 0.0045
2019-11-14 2019-09-30 13F CORCEPT THERA COMMON STOCK 218352102 290,186 -13,318 -4.39 4,100 21.16 0.0322
2019-08-14 2019-06-30 13F CORCEPT THERA COMMON STOCK 218352102 303,504 50,523 19.97 3,384 13.94 0.0278
2019-05-29 2019-03-31 13F/A-1 CORCEPT THERA COMMON STOCK 218352102 252,981 -320,855 -55.91 2,970 -61.26 0.0279
2019-05-14 2019-03-31 13F CORCEPT THERA COMMON STOCK 218352102 252,981 -320,855 2,970
2019-02-14 2018-12-31 13F CORCEPT THERA COMMON STOCK 218352102 573,836 456,584 389.40 7,667 366.36 0.0783
2018-12-06 2018-09-30 13F/A-1 CORCEPT THERA COMMON STOCK 218352102 117,252 117,252 1,644 0.0140
2018-11-14 2018-09-30 13F CORCEPT THERA COMMON STOCK 218352102 117,252 1,644 0.0140
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.